Ignite Creation Date:
2025-12-24 @ 2:48 PM
Ignite Modification Date:
2025-12-27 @ 8:14 PM
Study NCT ID:
NCT07101159
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-08-03
First Post:
2025-07-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage Patients
Sponsor:
Fujian Cancer Hospital
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
OBU-BC-II-304
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None